Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HQY total flavonoids
- Development stage
- Unknown
- Lead developer
- Nanjing Santong Pharmaceutical Technology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
HQY Total Flavonoids is a botanical drug candidate derived from Traditional Chinese Medicine (TCM) sources, specifically developed for the treatment of familial adenomatous polyposis (FAP). The drug is a purified flavonoid fraction, likely derived from *Scutellaria baicalensis* (Huangqin), and is being developed through a collaboration between Nanjing Santong Pharmaceutical Technology, Nanjing University of Chinese Medicine, and other Jiangsu-based research institutes. HQY is designed to inhibit the progression of intestinal polyps in patients with FAP, a genetic condition that predisposes individuals to colorectal cancer. Its mechanism of action involves the modulation of inflammatory pathways and the inhibition of the Wnt/beta-catenin signaling pathway, which are critical drivers of adenomatous polyp growth. Clinical trials in China have evaluated its efficacy in reducing polyp burden and delaying the need for surgical intervention.
- Other names
- HQY capsulesHuangqin total flavonoids
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CTNNB1 (Beta-catenin)
Beyond the preview
Go deeper on HQY total flavonoids.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HQY total flavonoids.